Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KT-CANOPY: Eplerenone for Cardiac Improvement in Kidney Transplant Recipients
NCT07828223Phase 3Not yet recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Feb 2027
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone, sponsored by CHRU de Nancy - Hôpital Central. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
eplerenone
Beyond the preview
Go deeper on NCT07828223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07828223.